Founded
Website
Recent investment activity
KANDO id: 27967
Corporate information
Official name
Atlas Venture Limited Liability Partnership
Registration country
Company type
Early-stage venture capital firm that creates and invests in biotechnology startup companies in the US.Funds managed
| Fund | Type | Vintage | Currency | Committed capital | IRR | x |
|---|---|---|---|---|---|---|
| Atlas Venture Fund IX | Venture | 2013 | USD | 265,000,000 | ||
| Atlas Venture Fund VII LP | Venture | 2006 | USD | 400,000,000 | ||
| Atlas Venture Fund VI LP | Venture | 2001 | USD | 967,000,000 | -0.32 % | 0.97 x |
| Atlas Venture Fund V LP | Venture | 2000 | USD | 750,000,000 | ||
| Atlas Venture Fund IV LP | Venture | 1999 | USD | 200,000,000 | ||
| Atlas Venture Fund III LP | Venture | 1997 | USD | 230,000,000 | ||
| Atlas Venture Europe Fund | Venture | |||||
| Atlas Venture Fund I | Venture | USD | 30,000,000 | |||
| Atlas Venture Fund II | Venture | USD | 62,000,000 |
Funding rounds
Investment preferences
Actual initial investment stage
Seed (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 11 of 11| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
|
Ark.com Inc | People search engine. | Seed Initial investment | |||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
ExtendMedia Corp | Provider of video content management systems | Series C | |||
|
|
ExtendMedia Corp | Provider of video content management systems | Series B | |||
|
|
Neurotech Pharmaceuticals Inc (Neurotech Inc) | Cell-based drugs for diseases of the eye. | Series B | |||
|
|
ExtendMedia Corp | Provider of video content management systems | Venture | |||
|
|
Compound Therapeutics Inc | Biotechnology company focused on protein-based drugs. | Series A | |||
|
|
SkillsVillage Inc | N/A | ||||
|
|
Phylogix Inc | Biotechnology company focused on tissue protection and oncology. | Series B | |||
|
|
ARCA biopharma Inc | Drug discovery based on pharmacogenomics of heart disease. | N/A | |||
|
|
Prestwick Pharmaceuticals Inc | A specialty pharmaceutical company engaged in the development and marketing of drugs for diseases of the CNS. | N/A | |||
|
|
Anadigm Inc | Developer of software-centric semiconductor products, based on field programmable analog technology | N/A |
Current team
Former team members
| Employee | Company | Position | |||
|---|---|---|---|---|---|
| Sonali De Rycker | Accel Partners Ltd | [email protected] | |||
| Martin Gibson | Accel Partners Ltd | [email protected] | |||
| Regina Hodits | Wellington Partners Venture Capital GmbH | ||||
|
Christopher Spray | Delin Ventures | Member
Investment Committee |